Navigation Links
ASMANEX(R) (Mometasone Furoate Dry Powder Inhaler) Now Approved in Japan for the Treatment of Bronchial Asthma in Adult Patients
Date:7/9/2009

Patients who are at increased risk of decreased bone mass should be monitored.

Inhaled steroids, including ASMANEX, may cause a reduction in growth velocity when administered to pediatric patients. The long-term effect on final adult height is unknown. Health care providers should closely follow the growth of children and adolescents taking corticosteroids by any route, and reduce each patient's dose to the lowest dose that effectively controls his/her symptoms.

ASMANEX may increase the risk of some eye problems such as cataracts, glaucoma, and increased intraocular pressure. Patients with a change in vision or a history of eye problems should be monitored by their health care provider.

Use ASMANEX as directed by your health care provider, since its ability to work in your lungs depends on regular use. Maximum benefit may take 1 to 2 weeks or longer. If your asthma symptoms do not improve, or get worse, contact your health care provider.

The most common side effects with ASMANEX in patients 4-11 years old include fever, allergic rhinitis, abdominal pain, vomiting, urinary tract infection, and bruise.

The most common side effects with ASMANEX in patients 12 years of age and older include headache, allergic rhinitis, sore throat, and upper respiratory infection.(2)

Additional important product information is available at: http://www.spfiles.com/piasmanex.pdf

About Schering-Plough Corporation

Schering-Plough is an innovation-driven, science-centered global health care company. Through its own biopharmaceutical research and collaborations with partners, Schering-Plough creates therapies that help save and improve lives around the world. The company applies its research-and-development platform
'/>"/>

SOURCE Schering-Plough Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Data Show Aerovances Aerovant(TM) Inhalation Powder is Well Tolerated in Asthma Patients
2. Carrington Subsidiary DelSite Initiates Critical Toxicology Studies of Its Nasal Powder Bird Flu Vaccine
3. Glivec(R) is the First Adjuvant Treatment Approved in the UK to Delay Return of Gastrointestinal Cancer After Surgery
4. Video: Afinitor(R) Approved in US as First Treatment for Patients With Advanced Kidney Cancer After Failure of Either Sunitinib or Sorafenib
5. CSL Behring Receives Orphan-Drug Exclusivity for RiaSTAP(TM), First and Only Approved Treatment of Acute Bleeding Episodes in Patients with Congenital Fibrinogen Deficiency
6. Pioneering Diamyd(R) Study to Prevent Childhood Diabetes Approved
7. Angiomax Will Retain Decision Resources Proprietary Clinical Gold Standard Status Over Current and New Therapies, Including Recently-Approved Efient, for the Treatment of NSTEMI
8. Nplate(R) Approved in the European Union for the Treatment of Chronic Immune (Idiopathic) Thrombocytopenic Purpura (ITP)
9. Positive Data From Lung Study May Lead to First FDA Approved Treatment for Pulmonary Fibrosis
10. MGuard(TM) Coronary Stent System Approved in Israel
11. Physicians Estimate That if Approved, Ceftobiprole Will Steal Nearly a Third of Zyvoxs Patient Share in the Treatment of Nosocomial Pneumonia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/3/2015)... , June 3, 2015  SurgiQuest®, Inc. ("SurgiQuest", ... technologies for minimally invasive surgery (MIS) announced today ... in over 250,000 procedures.  Adoption has risen rapidly ... last year, driven by the company,s expansion from ... as geographic expansion to over 45 countries.   ...
(Date:6/3/2015)... 02, 2015 Research and Markets  ( ... "Global Neurodegenerative Diseases Market 2015-2019" report ... diseases market to grow at a CAGR of ... report covers the present scenario and the growth ... the period 2015-2019. To calculate the market size, ...
(Date:6/3/2015)... CAMBRIDGE, Mass. , June 3, 2015  EIP ... dosing in phase 2 clinical development of VX-745 in ... brain penetrant, highly selective and potent inhibitor of the ... protein kinase (p38 MAPK alpha). "Recent human ... of disease in patients with symptomatic Alzheimer,s, while the ...
Breaking Medicine Technology:Rapid Procedure Growth With SurgiQuest's AirSeal System 2Global Neurodegenerative Diseases Market 2015-2019 - Reformulation of Marketed Drugs 2EIP Pharma announces first patient dosing in phase 2 clinical studies of a novel brain-targeted anti-inflammatory drug candidate, VX-745, for the treatment of Alzheimer's disease (AD) 2EIP Pharma announces first patient dosing in phase 2 clinical studies of a novel brain-targeted anti-inflammatory drug candidate, VX-745, for the treatment of Alzheimer's disease (AD) 3
... 2011 Eli Lilly and Company (NYSE: ... December 31 retirements of longtime senior leaders, Bryce D. Carmine ... spans 36 years, has led Lilly Bio-Medicines since its creation ... years, has led global manufacturing operations since 2007. Previously, both ...
... Fusion, the fastest growing EMR community in the US, ... 2011, is sold out.  Held at the Masonic Center ... will feature keynote speakers including Ryan Howard, Peter Thiel, ... National Coordinator for Health Information Technology with the Department ...
Cached Medicine Technology:Lilly Announces Changes in Senior Management 2Lilly Announces Changes in Senior Management 3Lilly Announces Changes in Senior Management 4Practice Fusion Connect 2011, the Health Tech Event of the Year 2Practice Fusion Connect 2011, the Health Tech Event of the Year 3Practice Fusion Connect 2011, the Health Tech Event of the Year 4
(Date:6/3/2015)... June 03, 2015 Accountable care organizations ... insurance products. Despite initial worries that these product types ... consumers, early signs indicate that product-based ACOs will continue ... explanations why in the June issue of Atlantic Information ... “I do think anecdotally that the backlash from HMOs ...
(Date:6/3/2015)... EMBARGOED FOR RELEASE UNTIL 2 P.M. ET, WEDNESDAY, JUNE ... Mother’s Home to Gas Wells , PITTSBURGH, June 3, 2015 ... natural gas wells drilled with hydraulic fracturing were more likely ... farther from such wells, according to a University of ... Pennsylvania birth records. , The finding does not prove ...
(Date:6/3/2015)... (PRWEB) June 03, 2015 AvePoint, ... platforms and devices, announced today that it has won ... Collaboration and Content. The company was honored among a ... excellence in innovation and implementation of customer solutions based ... Partner of the Year Awards – including the 2014 ...
(Date:6/3/2015)... “ Harmony ” was featured on NewsWatch as part ... latest and coolest applications on the market for iOS, Android, ... expert, conducted the app review and shared with viewers how ... aspect of their life. , A common mistake people make ... in their life. However, hypnotherapy is intended for anyone who ...
(Date:6/3/2015)... (PRWEB) June 03, 2015 On June 22, ... majority of genetic drug sensitivity (pharmacogenetic) testing that it has ... impact as many as 19 million of the 49 million ... of costly and life-threatening adverse drug events.(1) Sadly, if it ... millions. , Precision Medicine, the use of an individual’s genetic ...
Breaking Medicine News(10 mins):Health News:Product-Based ACOs Are Poised for Growth, Industry Observers Tell AIS Newsletter 2Health News:Product-Based ACOs Are Poised for Growth, Industry Observers Tell AIS Newsletter 3Health News:Fracking Proximity Associated with Lower Birth Weight 2Health News:Fracking Proximity Associated with Lower Birth Weight 3Health News:Fracking Proximity Associated with Lower Birth Weight 4Health News:AvePoint Wins 2015 Microsoft Partner of the Year Award for Collaboration and Content 2Health News:AvePoint Wins 2015 Microsoft Partner of the Year Award for Collaboration and Content 3Health News:An Application to Enjoy Hypnotherapy Sessions at Home was featured on NewsWatch Television 2Health News:Medicare Limiting Coverage Benefit for Drug Sensitivity Testing on June 22, 2015 2Health News:Medicare Limiting Coverage Benefit for Drug Sensitivity Testing on June 22, 2015 3Health News:Medicare Limiting Coverage Benefit for Drug Sensitivity Testing on June 22, 2015 4Health News:Medicare Limiting Coverage Benefit for Drug Sensitivity Testing on June 22, 2015 5Health News:Medicare Limiting Coverage Benefit for Drug Sensitivity Testing on June 22, 2015 6Health News:Medicare Limiting Coverage Benefit for Drug Sensitivity Testing on June 22, 2015 7
... push towards cultural changes that promote patient safety.ENGLEWOOD, ... developer of technology for the safe handling, packaging ... of a targeted campaign recognizing patient safety. ... to emphasize the need for a true cultural ...
... traceability posed by regulated medical wasteCLEVELAND, March 10 ... in label, packaging , promotion and identification ... reusable labeling solution to meet stringent regulatory standards ... biomedical waste. Subject to governmental regulations, medical waste ...
... 10, 2009 at 4:30 p.m. Eastern TimeMOUNTAIN VIEW, Calif., ... ALXA ) reported today financial results for the fourth ... an update on its product development candidates. The ... 31, 2008, as reported in accordance with accounting principles ...
... available in French . , Loss of ... boomers. That fear has resulted in a budding industry for ... and My Brain Trainer which in 2007 generated $80 ... of brain training is simple: participants must complete a series ...
... found for the first time that maintenance therapy ... and prednisone (CVP) therapy improves progression-free survival in patients ... Hochster, M.D. of NYU Langone Medical Center, lead author ... in the Journal of Clinical Oncology . , ...
... Company to host seminar Tuesday, March 17, 2009, from 8:30 ... ChanTest, the leading expert in ion channels and GPCRs ... safety - will feature the latest in its expanding line ... of Toxicology conference March 15-19, in Baltimore, Maryland. ChanTest,s growing ...
Cached Medicine News:Health News:Baxa Corporation Launches 'Culture of Safety' Campaign to Recognize National Patient Safety Awareness Week 2Health News:Baxa Corporation Launches 'Culture of Safety' Campaign to Recognize National Patient Safety Awareness Week 3Health News:Kennedy Group Applies Its Packaging Expertise to Reusable Labeling in Handling Biomedical Waste Disposal 2Health News:Kennedy Group Applies Its Packaging Expertise to Reusable Labeling in Handling Biomedical Waste Disposal 3Health News:Kennedy Group Applies Its Packaging Expertise to Reusable Labeling in Handling Biomedical Waste Disposal 4Health News:Alexza Reports 2008 Year-End Financial Results and Updates Clinical Pipeline Status 2Health News:Alexza Reports 2008 Year-End Financial Results and Updates Clinical Pipeline Status 3Health News:Alexza Reports 2008 Year-End Financial Results and Updates Clinical Pipeline Status 4Health News:Alexza Reports 2008 Year-End Financial Results and Updates Clinical Pipeline Status 5Health News:Alexza Reports 2008 Year-End Financial Results and Updates Clinical Pipeline Status 6Health News:Alexza Reports 2008 Year-End Financial Results and Updates Clinical Pipeline Status 7Health News:Alexza Reports 2008 Year-End Financial Results and Updates Clinical Pipeline Status 8Health News:Alexza Reports 2008 Year-End Financial Results and Updates Clinical Pipeline Status 9Health News:Alexza Reports 2008 Year-End Financial Results and Updates Clinical Pipeline Status 10Health News:Alexza Reports 2008 Year-End Financial Results and Updates Clinical Pipeline Status 11Health News:Can mental training games help prevent Alzheimer's? 2Health News:Study shows that maintenance rituximab is useful for advanced indolent lymphoma 2Health News:ChanTest to Highlight Expanded Ion Channel and GPCR Services and Cell Lines, Including FDA Critical Path Safety Profiling Tools at ToxExpo, Booth 3056 2Health News:ChanTest to Highlight Expanded Ion Channel and GPCR Services and Cell Lines, Including FDA Critical Path Safety Profiling Tools at ToxExpo, Booth 3056 3
... on-the-spot reference guide for ... On the wards, in ... or at the bedside, ... access to reliable, clinically ...
This easy-to-navigate reference provides clear, current, clinically proven recommendations for diagnosis and treatment of neurologic disorders....
... enable all those involved with healthcare decisions ... very latest evidence in their field of ... each year as the volume of evidence ... delivering the best single source available for ...
Treatment Strategies in Cardiovascular Medicine...
Medicine Products: